MGB Wealth Management LLC raised its holdings in Invesco Pharmaceuticals ETF (NYSEARCA:PJP – Free Report) by 11.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 21,976 shares of the company’s stock after acquiring an additional 2,345 shares during the quarter. MGB Wealth Management LLC owned 0.65% of Invesco Pharmaceuticals ETF worth $1,815,000 as of its most recent filing with the SEC.
Other institutional investors also recently made changes to their positions in the company. Howe & Rusling Inc. purchased a new stake in shares of Invesco Pharmaceuticals ETF during the 3rd quarter worth approximately $48,000. FMR LLC raised its holdings in Invesco Pharmaceuticals ETF by 29.4% during the third quarter. FMR LLC now owns 1,057 shares of the company’s stock worth $92,000 after purchasing an additional 240 shares during the last quarter. Secure Asset Management LLC acquired a new position in Invesco Pharmaceuticals ETF during the third quarter worth $229,000. JPMorgan Chase & Co. boosted its position in Invesco Pharmaceuticals ETF by 241.7% during the third quarter. JPMorgan Chase & Co. now owns 4,046 shares of the company’s stock worth $352,000 after purchasing an additional 2,862 shares in the last quarter. Finally, Grimes & Company Inc. acquired a new stake in Invesco Pharmaceuticals ETF in the fourth quarter valued at $354,000.
Invesco Pharmaceuticals ETF Stock Up 0.1 %
NYSEARCA:PJP opened at $86.45 on Thursday. Invesco Pharmaceuticals ETF has a 52-week low of $75.33 and a 52-week high of $89.87. The stock has a fifty day simple moving average of $84.27 and a 200-day simple moving average of $85.84. The company has a market capitalization of $293.07 million, a PE ratio of 21.48 and a beta of 0.61.
Invesco Pharmaceuticals ETF Company Profile
PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.
Recommended Stories
- Five stocks we like better than Invesco Pharmaceuticals ETF
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Will Falling Bond Yields Send These 2 Small Caps Soaring?
- What Are Dividend Champions? How to Invest in the Champions
- These 2 Tech Stocks Are Surging Back After a Q4 2024 Plunge
- Stock Dividend Cuts Happen Are You Ready?
- Digital Turbine Roars Back—What’s Driving the Ad Tech Surge?
Want to see what other hedge funds are holding PJP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Pharmaceuticals ETF (NYSEARCA:PJP – Free Report).
Receive News & Ratings for Invesco Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
